30 Day Trial

Orthofix Reports 3Q18 Revenue of $111.7MM, +6.1% vs. 3Q17


Orthofix performance driven by bone growth and trauma products with 3Q18 revenue of US $111.7MM, +6.1% vs. 3Q17.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.